Showing results (11-20 of 107) with videos related to
Sort By:
Pageof 11
Molecular Cancer Research : MCR|January 17, 2009
Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?Mark Wade, Geoffrey M WahlThe International Journal of Biochemistry & Cell Biology|May 15, 2007
MDM2 and MDM4: p53 regulators as targets in anticancer therapyFranck Toledo, Geoffrey M WahlNature Reviews. Cancer|November 28, 2006
Regulating the p53 pathway: in vitro hypotheses, in vivo veritasFranck Toledo, Geoffrey M WahlMolecular and Cellular Biology|October 10, 2007
Deregulated E2f-2 underlies cell cycle and maturation defects in retinoblastoma null erythroblastsAlexandra Dirlam, Benjamin T Spike, Kay F MacleodBlood|June 15, 2007
Hypoxic stress underlies defects in erythroblast islands in the Rb-null mouseBenjamin T Spike, Benjamin C Dibling, Kay F MacleodAnnual Review of Pathology|October 13, 2023
Cancer as a Disease of Development Gone AwryBen Z Stanger, Geoffrey M WahlCell Cycle (Georgetown, Tex.)|February 3, 2005
A new twist in the feedback loop: stress-activated MDM2 destabilization is required for p53 activationJayne M Stommel, Geoffrey M WahlCancer Cell|May 26, 2012
What a difference a phosphate makes: life or death decided by a single amino acid in MDM2Yao-Cheng Li, Geoffrey M WahlThe EMBO Journal|March 19, 2004
Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activationJayne M Stommel, Geoffrey M WahlGenome Biology|November 14, 2013
Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterpartsAdam D Pfefferle, Jason I Herschkowitz, Jerry Usary, et al.Pageof 11